
11 - 50 employees
Founded 2020
🏥 Healthcare
🤖 Artificial Intelligence
☁️ SaaS
💰 $23M Series B - Imagene AI on 2025-06
Healthcare • Artificial Intelligence • SaaS
Imagene AI is an oncology-focused company that provides a SaaS platform (OI Suite / CanvOI) powered by a proprietary Cross-Modality Intelligence Engine. The company continuously learns from imaging, histopathology, gene expression, mutational profiles, and clinical records using deep learning, foundation models and large language models to enable biomarker discovery, mechanism-of-action exploration, patient identification and trial optimization for biopharma and clinical teams. Imagene AI emphasizes rapid, AI-enabled biomarker detection and digital pathology workflows to shorten time-to-treatment and improve clinical trial design and therapeutic success, and partners with healthcare and life-sciences organizations.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 14
Senior Director expanding Imagene’s AI-powered digital pathology partnerships with US pharma and biotech organizations. Driving enterprise sales, drug-development collaborations, and oncology growth.
🇺🇸 United States – Remote
💰 $23M Series B - Imagene AI on 2025-06
⏰ Full Time
🟠 Senior
💰 Business Development (BDR)
👻 Ghost score 12%
🕒 August 21
Head of Business Development expanding pharmaceutical and biotech partnerships for Imagene’s AI-powered digital pathology solutions. Driving enterprise sales, revenue growth, and precision medicine programs.
🇺🇸 United States – Remote
💰 $23M Series B - Imagene AI on 2025-06
⏰ Full Time
🔴 Lead
💰 Business Development (BDR)
👻 Ghost score 18%